Saturday, June 14, 2025

USA-China Tensions Transform Global Market

After the U.S. elections, relations between the...

EssilorLuxottica to Acquire Optegra Group, a Leading European Eye Care Network

COMPANIESEssilorLuxottica to Acquire Optegra Group, a Leading European Eye Care Network

EssilorLuxottica has announced the signing of an agreement to acquire Optegra Group, one of the fastest-growing ophthalmology clinic networks in Europe. In Poland alone, Optegra operates 13 eye clinics and has performed over one million ophthalmological procedures to date.

Optegra is a rapidly expanding, integrated eye care platform active in five European countries: Poland, the United Kingdom, the Czech Republic, Slovakia, and the Netherlands. Since 2023, the group has completed eight acquisitions across these markets, expanding access to specialized ophthalmic care and introducing AI-driven solutions for patient qualification and monitoring.

The transaction, under which EssilorLuxottica will acquire Optegra from private equity fund MidEuropa, aligns with the Group’s long-term strategy to integrate medical services, advanced technologies, and AI-powered solutions.

“The acquisition of Optegra marks a step into a new era of ophthalmology – one that integrates comprehensive eye care, advanced diagnostics, therapeutic interventions, and surgical treatments into a single, unified platform,” said Francesco Milleri, CEO of EssilorLuxottica, and Paul du Saillant, Deputy CEO. “Optegra, together with its clinical team, will bring new medical competencies to the Group, allowing us to offer the most advanced technologies and treatment methods through a single, trusted system. Leveraging our growing expertise in AI and big data, we aim to provide patients with personalized and cohesive care pathways.”

Expanding the Vision Beyond Eyewear

EssilorLuxottica has been consistently expanding its portfolio beyond eyewear and lenses, venturing into AI-powered technologies, wearable medical devices, and scientifically validated vision care solutions that improve the quality of life for millions around the globe.

“Joining forces with EssilorLuxottica marks a new chapter for Optegra — as a partner of the global leader in vision care,” said Dr. Peter Byloos, CEO of Optegra Eye Health Care. “By combining the global reach and innovation capacity of EssilorLuxottica with our clinical expertise, we can truly redefine the paradigm of ophthalmic care in Europe — offering patients modern, digital, and coordinated therapeutic solutions.”

A Pan-European Ophthalmology Leader

Operating under the brands Optegra, Lexum, and Iris, the group manages a network of over 70 hospitals and diagnostic centers across Europe. Optegra offers both medical and refractive procedures, supported by AI systems at the qualification and post-operative stages. Its services include cataract surgery, treatment of age-related macular degeneration (AMD), glaucoma therapy, phakic lens implants, laser vision correction, and refractive lens exchange — available to both private patients and through public healthcare reimbursement systems.

“For the clinical community and patients in Poland, this is a breakthrough moment. It’s an opportunity to build a forward-looking model of eye care that is accessible to a broader population — starting from prevention and vision health protection,” commented Agnieszka Szpara, CEO of Optegra Poland.

Transaction Completion Expected in H2 2025

The deal is expected to close in the second half of 2025, pending regulatory approvals and standard closing conditions.

“We are proud of the pace and scale of Optegra’s development over the past two years. Together with the management team, we achieved dynamic organic growth, completed strategic acquisitions, entered new markets, and introduced groundbreaking AI innovations,” said Robert Knorr, Managing Partner at MidEuropa. “We believe EssilorLuxottica is the ideal partner to support Optegra in its next phase as a pan-European leader in eye care.”

EssilorLuxottica is listed on Euronext Paris, with a market capitalization exceeding €110 billion. In 2024, the Group reported €26.5 billion in revenue, nearly €10 billion of which was generated in the EMEA region.

Source: ManagerPlus

Check out our other content
Related Articles
The Latest Articles